BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32102533)

  • 1. Potency of Pfeiffer's Crystallization to Analyze Oral Leukoplakia and Squamous Cell Carcinoma.
    Makkar V; Kamboj M; Narwal A; Kapoor RK
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):517-522. PubMed ID: 32102533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of crystallization patterns in oral potentially malignant disorders and oral malignancies: A prospective study.
    Prakash AJ; Surendra KS; Lakshmi MV; Shetty V; Jogi Reddy MM; Thomas VJ
    J Cancer Res Ther; 2023; 19(5):1170-1175. PubMed ID: 37787280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytopathological tests for early detection of oral carcinogenesis.
    Salgueiro AP; Martelli FT; D'Ávila SR; Milnikel TR; Koehler-Santos P; Maraschin BJ; da Silva VP; Rados PV; Visioli F
    Eur J Cancer Prev; 2020 Jan; 29(1):73-79. PubMed ID: 30913094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An insight into crystallization test: A neoteric approach for screening premalignant and malignant lesions.
    Rawat G; Kureel K; Urs AB
    J Cancer Res Ther; 2020; 16(3):440-444. PubMed ID: 32719248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Diagnostic Role of Methyl Green-Pyronin Y Staining in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Exfoliative Cytology-Based Cytomorphometric Analysis.
    Raman RK; Kamboj M; Narwal A
    Acta Cytol; 2019; 63(5):401-410. PubMed ID: 31112943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Coexpression of MUC1 and MUC4 in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    Rathee R; Devi A; Narwal A; Kamboj M; Singh S
    Head Neck Pathol; 2021 Sep; 15(3):831-842. PubMed ID: 33544383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
    Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
    J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic reliability of fine needle aspiration cytology against histopathology for the diagnosis of oral squamous cell carcinoma and oral leukoplakia.
    Olekar ST; Sangeeta T; Kumar YS; Gururaj M
    J Contemp Dent Pract; 2012 Jul; 13(4):545-9. PubMed ID: 23151707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral medicine 8. Leukoplakia of the oral mucosa].
    Schepman KP; van der Meij EH; de Visscher JG
    Ned Tijdschr Tandheelkd; 2013; 120(7-8):384-90. PubMed ID: 23923441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for oral precancer with noninvasive genetic cytology.
    Bremmer JF; Graveland AP; Brink A; Braakhuis BJ; Kuik DJ; Leemans CR; Bloemena E; van der Waal I; Brakenhoff RH
    Cancer Prev Res (Phila); 2009 Feb; 2(2):128-33. PubMed ID: 19174582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral brush cytology cell block immunocytochemistry in the diagnosis of oral leukoplakia and oral squamous cell carcinoma.
    Kujan O; Idrees M; Anand N; Soh B; Wong E; Farah CS
    J Oral Pathol Med; 2021 May; 50(5):451-458. PubMed ID: 33368584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    G D; Nandan SRK; Kulkarni PG
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative prediction of oral cancer risk in patients with oral leukoplakia.
    Liu Y; Li Y; Fu Y; Liu T; Liu X; Zhang X; Fu J; Guan X; Chen T; Chen X; Sun Z
    Oncotarget; 2017 Jul; 8(28):46057-46064. PubMed ID: 28545021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia.
    Ganavi BS; Patil S; Rao RS
    J Contemp Dent Pract; 2014 May; 15(3):294-9. PubMed ID: 25307809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma.
    Sridharan G; Ramani P; Patankar S
    J Cancer Res Ther; 2017; 13(3):556-561. PubMed ID: 28862226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer aided morphometric analysis of oral leukoplakia and oral squamous cell carcinoma.
    Gupta K; Gupta J; Miglani R
    Biotech Histochem; 2016; 91(4):251-4. PubMed ID: 26983454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of crystallization test for screening of oral squamous cell carcinoma with clinico-pathological correlation.
    Sarode SC; Sarode GS; Barpande S; Tupkari JV
    Indian J Dent Res; 2013; 24(4):464-7. PubMed ID: 24047839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoexpression of C4 Binding Protein in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    Mashhadiabbas F; Fayazi-Boroujeni M; Alizadeh A; Namdari M; Mirzaei SA
    Iran J Immunol; 2021 Jun; 18(2):95-102. PubMed ID: 34190690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.